Company Filing History:
Years Active: 1984
Title: Inventor Spotlight: Carl G. Magnusson
Introduction
Carl G. Magnusson, an innovative inventor based in Brussels, Belgium, is recognized for his contributions to the field of immunoassays. With a singular focus on enhancing detection techniques for haptens, his work exemplifies the intersection of scientific research and practical application in medical diagnostics.
Latest Patents
Magnusson holds one notable patent for a "Particle agglutination immunoassay with agglutinator for determining - A particle counting assay for haptens." This technique involves the mixing of a liquid sample, which may originate from human sources, with finely divided inert particles that bear the hapten or a specific analogue. The process includes the introduction of an agglutinator, like RF or C1q, along with a measured amount of antibody, deliberately insufficient to agglutinate all particles present. The resulting agglutination is then measured to determine the presence and quantity of the hapten, showcasing a novel approach for precise detection in medical testing.
Career Highlights
Carl G. Magnusson currently works at the International Institute of Cellular and Molecular Pathology, where his research focuses on improving diagnostic methodologies. His dedication to advancing immunological techniques has positioned him as a key figure in the pursuit of more effective and reliable testing methods.
Collaborations
Throughout his career, Magnusson has collaborated with notable coworkers, including Pierre L. Masson and Daniel Collet-Cassart. These partnerships illustrate the collaborative nature of scientific research, as multiple minds come together to innovate and advance the field of cellular and molecular pathology.
Conclusion
Carl G. Magnusson's work not only highlights his individual achievements but also contributes significantly to the broader medical community. His patent for a particle agglutination immunoassay reflects his commitment to improving diagnostic tools, ultimately enhancing patient care and advancing scientific knowledge in immunology.